(Nieder-Olm, Germany, August 2021) – TRACOE medical can still feel the effects of the Corona pandemic on business, but this is not the only reason for the continuing high demand. The manufacturer of medical devices and appliances for patients, who have had a tracheostomy or laryngectomy and need ventilation (respiratory care), with its headquarters in Nieder-Olm (Rhineland-Palatinate, Germany), also attributes its positive 2021 mid-year balance sheet, among other things, to strong growth in South America.
The XTR Group, whose members include not only TRACOE medical Germany but also the UK sister company KAPITEX Healthcare Ltd, the Dutch subsidiary MC Europe B. V. and the Austrian TRACOE medical, increased its total revenues by 3% compared to the previous year to around EUR 22.98 million. TRACOE medical Germany generated EUR 17.49 million of this in the first half-year alone, which is tantamount to 10.8% growth compared to the previous year.
Dr. Thomas Jurisch, Managing Director of TRACOE medical and spokesman for the Management Board: “So both the group and TRACOE medical Germany have exceeded their target, and this significantly by 8.8% and 11.5% respectively. We are very pleased about this, but we are also aware that it is partly due to the still greatly increased demand for our products for COVID-19 patients throughout the world”.
Internet Explorer ist ein veralteter Browser der von uns nicht mehr unterstützt wird. Bitte verwenden Sie einen aktuellen Browser, wie Microsoft Edge, Google Chrome oder Safari, für das beste Website-Erlebnis.